Endocan as a marker of endotheliitis in COVID-19 patients
Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19
Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents
Endocan as a marker of endotheliitis in COVID-19 patients
